In vitro metabolism of obovatol and its effect on cytochrome P450 enzyme activities in human liver microsomes

被引:10
|
作者
Joo, Jeongmin [1 ,2 ]
Lee, Doohyun [1 ,2 ]
Wu, Zhexue [1 ,2 ]
Shin, Jung-Hoon [1 ,2 ]
Lee, Hye Suk [3 ,4 ]
Kwon, Byoung-Mog [5 ]
Huh, Tae-Lin [6 ]
Kim, Yang-Weon [7 ]
Lee, Su-Jun [7 ]
Kim, Tae Wan [8 ]
Lee, Taeho [1 ,2 ]
Liu, Kwang-Hyeon [1 ,2 ]
机构
[1] Kyungpook Natl Univ, Coll Pharm, Taegu 702701, South Korea
[2] Kyungpook Natl Univ, Pharmaceut Sci Res Inst, Taegu 702701, South Korea
[3] Catholic Univ Korea, Coll Pharm, Puchon, South Korea
[4] Catholic Univ Korea, Integrated Res Inst Pharmaceut Sci, Puchon, South Korea
[5] Korea Res Inst Biosci & Biotechnol, Div Biomed Convergent, Taejon, South Korea
[6] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea
[7] Inje Univ, Coll Med, Pusan, South Korea
[8] Kyungpook Natl Univ, Coll Vet Med, Taegu 702701, South Korea
基金
新加坡国家研究基金会;
关键词
obovatol; microsomes; oxidation; glucuronidation; drug interaction; MAGNOLIA-OBOVATA; CARDIOPROTECTIVE AGENT; ANTIPLATELET ACTIVITY; COLON-CANCER; CELL-DEATH; KAPPA-B; NEUROTOXICITY; INHIBITION; PROSTATE; ISOFORMS;
D O I
10.1002/bdd.1837
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obovatol, a major constituent of the leaves of Magnolia obovata Thunb, is known to inhibit nuclear factor-B activity and arachidonic acid-induced platelet aggregation. This study was performed to identify the metabolites of obovatol in human liver microsomes. Human liver microsomes incubated with obovatol in the presence of NADPH and/or UDPGA resulted in the formation of six metabolites, M1M6. M1 and M2 were identified as hydroxyobovatol, on the basis of liquid chromatography/tandem mass spectrometric (LC-MS/MS) analysis. M1, M2 and obovatol were further metabolized to their glucuronide conjugates, obovatol-glucuronide (M3), obovatol-diglucuronide (M4) and hydroxyobovatol-glucuronide (M5 and M6). The inhibitory potency of obovatol on eight major human P450s was also investigated in human liver microsomes. In these experiments, obovatol strongly inhibited CYP2C19-mediated S-mephenytoin hydroxylase activity with an IC50 value of 0.8 mu m, which could have implications for drugdrug interactions. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
  • [21] In vitro metabolism of benidipine enantiomers by human liver microsomes and recombinant cytochrome P450 isoforms
    Yoon, Yune-Jung
    Kim, Hyunmi
    Seo, Kyung-Ah
    Kim, Kwon-Bok
    Kim, Min-Jung
    Cha, In-June
    Shin, Jae-Gook
    Liu, Kwang-Hyeon
    DRUG METABOLISM REVIEWS, 2006, 38 : 121 - 121
  • [22] The impact of porous silicon nanoparticles on human cytochrome P450 metabolism in human liver microsomes in vitro
    Ollikainen, Elisa
    Liu, Dongfei
    Kallio, Arttu
    Makila, Ermei
    Zhang, Hongbo
    Salonen, Jarno
    Santos, Helder A.
    Sikanen, Tiina M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 104 : 124 - 132
  • [23] Inhibitory Effects of Cedrol, β-Cedrene, and Thujopsene on Cytochrome P450 Enzyme Activities in Human Liver Microsomes
    Jeong, Hyeon-Uk
    Kwon, Soon-Sang
    Kong, Tae Yeon
    Kim, Ju Hyun
    Lee, Hye Suk
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2014, 77 (22-24): : 1522 - 1532
  • [24] Intraindividual Variation and Correlation of Cytochrome P450 Activities in Human Liver Microsomes
    Fang, Yan
    Gao, Jie
    Wang, Tong
    Tian, Xin
    Gao, Na
    Zhou, Jun
    Zhang, Hai-Feng
    Wen, Qang
    Jin, Han
    Xing, Yu-Rong
    Qiao, Hai-Ling
    MOLECULAR PHARMACEUTICS, 2018, 15 (11) : 5312 - 5318
  • [25] A comparison of cytochrome P450 activities in bactosomes, supersomes, and human liver microsomes
    Settle, K
    Madan, A
    Ogilvie, B
    Carrott, P
    Hussain, A
    Parkinson, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 105 - 105
  • [26] Kinetics of bromodichloromethane metabolism by cytochrome P450 isoenzymes in human liver microsomes
    Zhao, GY
    Allis, JW
    CHEMICO-BIOLOGICAL INTERACTIONS, 2002, 140 (02) : 155 - 168
  • [27] Metabolism of β-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450
    Grace, JM
    Aguilar, AJ
    Trotman, KM
    Brewer, TG
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (04) : 313 - 317
  • [28] Characterization of cytochrome p450 involved in the metabolism of ipriflavone in human liver microsomes
    Ji, Hye Young
    Kim, Hui Hyun
    Kim, Young Hoon
    Kim, Soon Ai
    Lee, Hye Suk
    DRUG METABOLISM REVIEWS, 2006, 38 : 47 - 47
  • [29] Cytochrome p450 specificity of metabolism and interactions of oxybutynin in human liver microsomes
    Lukkari, E
    Taavitsainen, P
    Juhakoski, A
    Pelkonen, O
    PHARMACOLOGY & TOXICOLOGY, 1998, 82 (04): : 161 - 166
  • [30] Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes
    Facciolá, G
    Hidestrand, M
    von Bahr, C
    Tybring, G
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (12) : 881 - 888